SCHEMBL2469795

SCHEMBL2469795

O=C(Nc1ccccc1)Oc1ccc(N2CCN(C(=O)c3ccccc3C(F)(F)F)CC2)nn1

nearest known ligand 0.71

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 13/20 0.71
DCTPP1 Q9H773 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466655 0.94 SCD (0.62) SCDDCTPP1
SCHEMBL2468540 0.94 SCD (0.62) SCDDCTPP1
SCHEMBL2465401 0.94 SCD (0.62) SCDDCTPP1
SCHEMBL2474516 0.93 SCD (0.74) SCDDCTPP1
SCHEMBL2470081 0.93 SCD (0.61) SCDDCTPP1
SCHEMBL2464869 0.91 SCD (0.60) SCDDCTPP1
SCHEMBL2468489 0.91 SCD (0.60) SCDDCTPP1
SCHEMBL2466329 0.91 SCD (0.60) SCDDCTPP1
SCHEMBL2466635 0.91 SCD (0.60) SCDDCTPP1
SCHEMBL2465005 0.91 SCD (0.60) SCDDCTPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed